0.19%| Prev Close: | 4,095.00 |
|---|---|
| Open: | 4,040.00 |
| Bid: | 4,000.00 |
| Ask: | 4,018.00 |
| 1y Target Est: | N/A |
| Beta: | N/A |
| Next Earnings Date: | N/A |
| Day's Range: | 3,930.00 - 4,040.00 |
|---|---|
| 52wk Range: | 25.40 - 4,040.00 |
| Volume: | 124,833 |
| Avg Vol (3m): | 91,136 |
| Market Cap: | N/A |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in ILS.
Headlines
- Evogene CEO Signals Possible U.S. Listing as Israel ‘Not Enough’at Bloomberg(Sun, May 12)
- Brainsway Sees Partnership as FDA Backs Depression Deviceat Bloomberg(Mon, Jan 21)
- Kamada to Babylon Seek U.S. Listing After Jump: Israel Overnightat Bloomberg(Thu, Jan 10)
- Kamada Said to Seek as Much as $50 Million in Nasdaq Listingat Bloomberg(Wed, Jan 9)
- Kamada Announces New Data on its Glassia Drug Supporting its Diabetes Activities and Treatment of Additional Therapeutic IndicationsBusiness Wire(Tue, Nov 6)
- Allot to Ceragon Widen Premium After Storm: Israel Overnightat Bloomberg(Wed, Oct 31)
- Kamada Rises to 18 Month High on Nasdaq Report: Tel Aviv Moverat Bloomberg(Tue, Oct 30)
Press Releases
Reports
- Kamada Ltd. (KMDA) - Pharmaceuticals & Healthcare - Deals and Alliances ProfileGlobalData(May 21)
- Kamada Ltd: Business description, financial summary, 3yr and interim financials,...Reuters Investment Profile(May 18)
- Wright Investors Service Comprehensive Report for Kamada LimitedWright Reports(May 2)